UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000038338
Receipt number R000043693
Scientific Title Prognostic significance of reserved liver function in recurrent hepatocellular carcinoma after primary hepatectomy
Date of disclosure of the study information 2019/10/19
Last modified on 2019/10/19 10:06:53

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Prognostic significance of reserved liver function in recurrent hepatocellular carcinoma after primary hepatectomy

Acronym

Prognostic significance of reserved liver function in recurrent hepatocellular carcinoma after primary hepatectomy

Scientific Title

Prognostic significance of reserved liver function in recurrent hepatocellular carcinoma after primary hepatectomy

Scientific Title:Acronym

Prognostic significance of reserved liver function in recurrent hepatocellular carcinoma after primary hepatectomy

Region

Japan


Condition

Condition

Hepatocellular carcinoma

Classification by specialty

Hepato-biliary-pancreatic surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

We investigated the Child-Pugh-related parameters aiming to reveal the prognostic significance of them in the patients with recurrent HCC.

Basic objectives2

Others

Basic objectives -Others

A retrospective study to investigate post-recurrent prognosis of HCC

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

overall survival after recurrence of HCC

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients who underwent a radical hepatectomy for primary HCC and had intrahepatic recurrences.

Key exclusion criteria

Patients who had extrahepatic recurrences.

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Ryo
Middle name
Last name Saito

Organization

University of Yamanashi

Division name

First Department of Surgery, Faculty of Medicine

Zip code

409-3898

Address

1110 Shimokato, Chuo, Yamanashi, Japan

TEL

055-273-7390

Email

rsaitoh@yamanashi.ac.jp


Public contact

Name of contact person

1st name Ryo
Middle name
Last name Saito

Organization

University of Yamanashi

Division name

First Department of Surgery, Faculty of Medicine

Zip code

409-3898

Address

1110 Shimokato, Chuo, Yamanashi, Japan

TEL

055-273-7390

Homepage URL


Email

rsaitoh@yamanashi.ac.jp


Sponsor or person

Institute

University of Yamanashi

Institute

Department

Personal name



Funding Source

Organization

Self funding

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

University of Yamanashi

Address

1110 Shimokato, Chuo, Yamanashi, Japan

Tel

055-273-7390

Email

rsaitoh@yamanashi.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2019 Year 10 Month 19 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

106

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2019 Year 08 Month 01 Day

Date of IRB

2019 Year 06 Month 13 Day

Anticipated trial start date

2019 Year 08 Month 01 Day

Last follow-up date

2019 Year 09 Month 30 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

This is a retrospective observational study using datasets collected from medical records and clinical database.


Management information

Registered date

2019 Year 10 Month 19 Day

Last modified on

2019 Year 10 Month 19 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000043693


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name